Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Biliary Tract Neoplasms × encorafenib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 17 Colorectal Neoplasms 9 Brain Neoplasms 6 Colonic Neoplasms 5 Neoplasms 2 Neoplasm Metastasis 2 Thyroid Neoplasms 1 Skin Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Multiple Myeloma 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Disease Progression 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1 Astrocytoma 1

Interventions

Gemcitabine 48 Cisplatin 35 Capecitabine 25 Oxaliplatin 23 durvalumab 16 Fluorouracil 16 Leucovorin 15 Irinotecan 10 lenvatinib 9 pembrolizumab 8 S 1 (combination) 8 Nivolumab 8 Immune Checkpoint Inhibitors 7 130-nm albumin-bound paclitaxel 7 tremelimumab 6 apatinib 6 camrelizumab 5 Trastuzumab 5 Blood Specimen Collection 5 irinotecan sucrosofate 4 Taxes 4 Liquid Biopsy 4 Folfox protocol 4 Drug Therapy 4 Bevacizumab 4 Albumin-Bound Paclitaxel 4 tislelizumab 3 surufatinib 3 anlotinib 3 Tegafur 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05615818 2025-04-23

SAFIR-ABC10

UNICANCER

Phase 3 Recruiting

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡